other
Westpoint Pharma Successfully Concluded CPHI China 2026 Exhibition

Westpoint Pharma Successfully Concluded CPHI China 2026 Exhibition

Showcasing High-Quality Pharmaceutical Excipients and Connecting with Global Industry Partners

 

Westpoint Pharma has successfully concluded its participation in CPHI China 2026, one of Asia’s most influential pharmaceutical exhibitions, held in Shanghai.

The exhibition provided an excellent platform for pharmaceutical companies, industry professionals, and global partners to exchange insights on the latest developments in pharmaceutical ingredients, excipients, and formulation technologies.

During the exhibition, Westpoint Pharma presented its comprehensive portfolio of pharmaceutical excipient solutions, including:

  • Microcrystalline Cellulose (MCC)
  • Mannitol
  • Anhydrous Dicalcium Phosphate (DCPA)
  • Silicified Microcrystalline Cellulose (SMCC)
  • Hydroxypropyl Methylcellulose (HPMC)

These products are widely applied in solid dosage formulations, including tablets and capsules, supporting pharmaceutical manufacturers with improved compressibility, flowability, stability, and formulation performance.

 

Successful Communication with Global Pharmaceutical Professionals

 

During CPHI China 2026, Westpoint Pharma had the opportunity to meet and communicate with pharmaceutical professionals from around the world. Our high-quality pharmaceutical excipient solutions, including MCC, Mannitol, DCPA, SMCC, and HPMC, received positive feedback and recognition from international customers.

 

Through face-to-face discussions, customers gained a deeper understanding of our product quality, manufacturing capabilities, and technical support services. The trust and recognition from global partners encourage us to continuously improve our excipient solutions and provide more reliable support for pharmaceutical manufacturers worldwide.

 

Delivering Reliable Pharmaceutical Excipient Solutions Worldwide

As a professional pharmaceutical excipients manufacturer, Westpoint Pharma is committed to providing high-quality excipient products and technical support for global pharmaceutical companies.

 

Through continuous improvement in manufacturing technology, quality management, and application expertise, Westpoint Pharma aims to support customers in developing efficient and reliable pharmaceutical formulations.

The successful conclusion of CPHI China 2026 marks another important milestone in Westpoint Pharma’s global expansion journey. We look forward to building long-term partnerships and creating more opportunities with pharmaceutical professionals around the world.

 

About Westpoint Pharma

Westpoint Pharma specializes in the development and manufacturing of pharmaceutical excipients, offering high-quality solutions including Microcrystalline Cellulose (MCC), Mannitol, DCPA, SMCC, and HPMC.

With advanced manufacturing capabilities, strict quality control systems, and professional technical support, Westpoint Pharma provides reliable excipient solutions for pharmaceutical manufacturers worldwide.